Adaptive Biotechnologies and Microsoft launch virtual ImmuneRACE study to inform novel COVID-19 diagnostics to address unmet needs in testing $ADPT $MSFT $LH #coronavirus #COVID2019 https://t.co/1LVNA6iNxr